Supplement company Lemme has rebranded its GLP-1 Daily supplement to Lemme Reset, marketing the product alongside terms such as GLP-1 production support.
The capsules promise to help "reduce hunger and cravings, support [the] body’s GLP-1 production and support fat reduction, along with healthy diet & exercise."
The company has also announced the launch of a separate GLP-1 production support product, which it says provides an "accessible daily option for people interested in GLP-1 production support."
The new supplement has a different formulation and positioning from Lemme Reset, positioning itself for consumers just starting their metabolic wellness journeys with a targeted, GLP-1-focused product.
From launch to lawsuits
Co-founded by Kourtney Kardashian Barker, the supplement firm launched a "natural GLP-1 supplement" back in 2024 named GLP-1 Daily.
However, the company faced regulatory scrutiny around the product, including class-action lawsuits filed in California and New York, with claimants alleging the brand engaged in deceptive marketing.
The lawsuits alleged that Lemme had tried to cash in on the popularity of prescription GLP-1 agonist weight-loss drugs such as Ozempic and Wegovy by marketing the supplement as a natural, cheaper alternative that could trigger similar weight-loss and un-hunger effects.
Despite GLP-1 appearing in its name, the supplement did not contain GLP-1 itself and instead used plant extracts.
The lawsuits also challenged whether the available scientific evidence supported claims that the ingredients could increase natural GLP-1 levels sufficiently to produce meaningful weight loss or replicate the effects of pharmaceutical GLP-1 agonists.
The New York class action was voluntarily dismissed in April 2025, although Lemme continues to face a separate class action in California.
Same formula, new positioning
Lemme Reset retains the same underlying formulation as the original GLP-1 Daily supplement, containing Morosil Red Orange Fruit Extract, at 400 mg, as well as 200 mg Eriomin Lemon Fruit Extract and 176.5 mg Supresa Saffron Extract.
However, Lemme markets the rebranded product alongside clearer disclaimers emphasising that it does not contain synthetic GLP-1, is not an agonist drug and only aims to support the body's natural production of GLP-1 via plant extracts.
Lemme also expands its GLP-1 range
The company has also launched a new product, GLP-1 Production Support Capsules, available exclusively at Walmart.
Not yet a Subscriber?
This is a small extract of the full article which is available ONLY to premium content subscribers. Click below to get premium content on Nutraceutical Business Review.
Subscribe now Already a subscriber? Sign in here.
